Faculty Opinions recommendation of RNA unwinding by the Trf4/Air2/Mtr4 polyadenylation (TRAMP) complex.

Author(s):  
Daniel Reines
Keyword(s):  
2012 ◽  
Vol 109 (19) ◽  
pp. 7292-7297 ◽  
Author(s):  
H. Jia ◽  
X. Wang ◽  
J. T. Anderson ◽  
E. Jankowsky
Keyword(s):  

2015 ◽  
Vol 108 (2) ◽  
pp. 14a-15a
Author(s):  
Eric M. Patrick ◽  
Sukanya Srinivasan ◽  
Eckhard Jankowsky ◽  
Matthew J. Comstock

2021 ◽  
Vol 120 (3) ◽  
pp. 93a
Author(s):  
Keith J. Mickolajczyk ◽  
Patrick M. Shelton ◽  
Michael Grasso ◽  
Xiaocong Cao ◽  
Sara E. Warrington ◽  
...  
Keyword(s):  

2000 ◽  
Vol 74 (20) ◽  
pp. 9732-9737 ◽  
Author(s):  
Shin C. Chang ◽  
Ju-Chien Cheng ◽  
Yi-Hen Kou ◽  
Chuan-Hong Kao ◽  
Chiung-Hui Chiu ◽  
...  

ABSTRACT The nonstructural protein 3 (NS3) of hepatitis C virus (HCV) possesses protease, nucleoside triphosphatase, and helicase activities. Although the enzymatic activities have been extensively studied, the ATP- and RNA-binding domains of the NS3 helicase are not well-characterized. In this study, NS3 proteins with point mutations in the conserved helicase motifs were expressed inEscherichia coli, purified, and analyzed for their effects on ATP binding, RNA binding, ATP hydrolysis, and RNA unwinding. UV cross-linking experiments indicate that the lysine residue in the AX4GKS motif is directly involved in ATP binding, whereas the NS3(GR1490DT) mutant in which the arginine-rich motif (1486-QRRGRTGR-1493) was changed to QRRDTTGR bound ATP as well as the wild type. The binding activity of HCV NS3 helicase to the viral RNA was drastically reduced with the mutation at Arg1488 (R1488A) and was also affected by the K1236E substitution in the AX4GKS motif and the R1490A and GR1490DT mutations in the arginine-rich motif. Previously, Arg1490 was suggested, based on the crystal structure of an NS3-deoxyuridine octamer complex, to directly interact with the γ-phosphate group of ATP. Nevertheless, our functional analysis demonstrated the critical roles of Arg1490 in binding to the viral RNA, ATP hydrolysis, and RNA unwinding, but not in ATP binding.


2006 ◽  
Vol 20 (4) ◽  
Author(s):  
David N Frick ◽  
Christopher M Frenz ◽  
Angela M.I. Lam

BioMedicine ◽  
2019 ◽  
Vol 9 (4) ◽  
pp. 27
Author(s):  
Nai-Wen Chang ◽  
Yi-Ping Huang

Background: The activation of peroxisome proliferator-activated receptor alpha (PPARα) has been shown to reprogram tumor metabolism and exhibits great potential for treating anti-oral tumorigenesis. Methods: In this study, we used a pathway-based strategy to explore possible functional pathways involved in the anticancer activity of PPARα in oral cancer cells through next-generation sequencing (NGS) and bioinformatic approaches. Results: We found that 3919 genes were upregulated and 1060 genes were downregulated through PPARα activation. These genes were mainly involved in the proteasomal, mRNA surveillance, spliceosomal, RNA transport, and RNA degradation pathways, as indicated by GO and KEGG enrichment analysis. Importantly, a total of 13 upregulated genes in the RNA degradation pathway were identified including 3 core exosome factor genes (RRP43, RRP42, and CSL4), 2 TRAMP complex genes (TRF4 and Mtr4), 2 exosome cofactor genes (RRP6 and MPP6), 2 CCR4-NOT complex genes (CNOT2 and CNOT3), 2 Ski complex genes (SKI2 and Ski3), 1 decapping complex gene (EDC4), and 1 gene involved in 5’ exoribonuclease activity (XRN1). Conclusion: Our findings suggest that the activation of PPARα to upregulate the RNA degradation pathway might provide a new strategy for oral cancer treatment.


Sign in / Sign up

Export Citation Format

Share Document